Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |